Inizio Ignite leaders argue static, milestone-driven launch plans fall short and AI sharpens execution only when built on a sound strategy.
Ryan Wyrtzen
Advertisement
Ryan Wyrtzen is a partner at Inizio Ignite.
Articles by Ryan Wyrtzen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How an FTZ Builds More Flexibility Into Pharmaceutical Inventory Strategy
2
Q&A: Kerem Tokel on Pharma Cargo Theft Hotspots and the Shift to Outbound Diversion
3
What DOL’s Final PBM Rule Means for Rebates and Formularies
4
Why the Best Drug Launches Are Built to Adapt
5